Matthew Futvoye, MD
Orthopaedic Surgery · Flowood, MSNPI 1124221601
Payments from drug & device makers
Across 69 payments — averaging $92.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medical Device Business Services, Inc.$3K
- Johnson & Johnson$1K
- Abbott$903
- Davol Inc.$183
- Smith+Nephew$124
- Amgen$97
- plus $558 from 15 others
What the payments were for
- Consulting fees$3,37553%
- Food & beverage$3,00847%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medical Device Business Services, Inc. | 3 | $3,482 |
| Johnson & Johnson(2 entities) | 15 | $1,037 |
| Abbott | 9 | $903 |
| Davol Inc. | 7 | $183 |
| Smith+Nephew | 2 | $124 |
| Amgen(2 entities) | 7 | $97 |
| Pacira Therapeutics, Inc. | 4 | $79 |
| Pacira Pharmaceuticals Incorporated | 4 | $76 |
| Sanara Medtech Inc. | 1 | $72 |
| Kerecis Limited | 2 | $66 |
| Ferring Pharmaceuticals Inc. | 3 | $61 |
| Pfizer | 3 | $43 |
| Stryker | 1 | $41 |
| Philips North America LLC | 1 | $21 |
| Total Joint Orthopedics, Inc. | 1 | $21 |
| Solventum Corporation | 1 | $17 |
| Vertex | 1 | $14 |
| Heron Therapeutics, Inc. | 1 | $13 |
| Molnlycke Health Care US, LLC | 1 | $12 |
| Bioventus LLC | 1 | $12 |
| Medela LLC | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ATTUNE$461
- Proclaim IPG$363
- PROCLAIM$348
- Navio Surgical System$111
- SIGMA$107
How this compares
$6,383 in reported general payments places this provider in the 55th percentile of 170 orthopaedic surgery providers in Mississippi.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 65 | $1,461 |
| Diclofenac Sodium | 38 | $1,132 |
| Meloxicam | 351 | $1,041 |
| Mupirocin | 117 | $764 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 31 | $379 |
| Ibuprofen | 41 | $358 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 31 | $310 |
| Methylprednisolone | 47 | $240 |
| Ondansetron OdtOndansetron | 14 | $207 |
| Cyclobenzaprine Hcl | 48 | $167 |
| Gabapentin | 17 | $94 |
| Tramadol Hcl | 32 | $83 |
| Cephalexin | 55 | $76 |
| Clindamycin Hcl | 11 | $30 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Flowood
- Steven HendrixFlowood$15K
- Michael DulskeFlowood$10K
- Matthew GravesJackson$1.2M
- Edward HobgoodJackson$392K
- George van OstenTupelo$322K
- Hanna MitiasNew Albany$249K
- Stephen SouthworthTupelo$160K
- Jeff AlmandJackson$137K
- Jamey BurrowJackson$130K
- Robert MehrleJackson$125K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.